Nevertheless, when compared with existing markers of lung cancer, the sensitivity and specificity for Cyfra 21-1 were 43% and 89%, for CEA they were 57% and 92%, for SCC they were 75% and 90%, and for EGFR they were 71% and 80%, respectively. The gene discussed is CEACAM5; the disease is lung cancer.